Judith received her M.B.A. in finance from Columbia Business School in the U.S. and her B.Sc. in Biology from the University of Toronto.
Prior to joining MaRS Innovation, Judith was a principal with Genesys Capital Partners, one of the largest Canadian-based venture-capital firms focused on the life sciences industry. She is a past Director of Insception, Millenium Biologix Corp., Plexagen Diagnostics, and Zelos Therapeutics Inc. Previously, Judith was a partner with Royal Bank Capital Partners Life Sciences Fund and, prior to that, Director of Bio/pharmaceutical Research at Drug Royalty Corporation.
